ES2113881T3 - Derivados y analogos de acido 2-desoxi-2,3-didehidro-n-acetil neuraminico y su utilizacion como agentes antivirales. - Google Patents

Derivados y analogos de acido 2-desoxi-2,3-didehidro-n-acetil neuraminico y su utilizacion como agentes antivirales.

Info

Publication number
ES2113881T3
ES2113881T3 ES91908682T ES91908682T ES2113881T3 ES 2113881 T3 ES2113881 T3 ES 2113881T3 ES 91908682 T ES91908682 T ES 91908682T ES 91908682 T ES91908682 T ES 91908682T ES 2113881 T3 ES2113881 T3 ES 2113881T3
Authority
ES
Spain
Prior art keywords
didehidro
analogs
derivatives
acid
neuraminico
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91908682T
Other languages
English (en)
Inventor
Itzstein Laurence Mark Von
Wen-Yang Wu
Tho Van Phan
Basil Danylec
Betty Jin
Peter Malcolm Colman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biota Scientific Management Pty Ltd
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Application granted granted Critical
Publication of ES2113881T3 publication Critical patent/ES2113881T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE DESCRIBEN DERIVADOS Y ANALOGOS DEL ACIDO 2 ,3 DIDEHIDRO CEUTICAS, LOS METODOS PARA SU PREPARACION Y SU EMPLEO EN EL TRATAMIENTO DE INFECCIONES VIRICAS, EN PARTICULAR DE LA GRIPE.
ES91908682T 1990-04-24 1991-04-24 Derivados y analogos de acido 2-desoxi-2,3-didehidro-n-acetil neuraminico y su utilizacion como agentes antivirales. Expired - Lifetime ES2113881T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPJ980090 1990-04-24
AUPK289690 1990-10-19
AUPK453791 1991-02-11
PCT/AU1991/000161 WO1991016320A1 (en) 1990-04-24 1991-04-24 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents

Publications (1)

Publication Number Publication Date
ES2113881T3 true ES2113881T3 (es) 1998-05-16

Family

ID=27157556

Family Applications (2)

Application Number Title Priority Date Filing Date
ES97100119T Expired - Lifetime ES2313730T3 (es) 1990-04-24 1991-04-24 Derivados y analogos del acido 2-desoxi-2,3-deshibro-n-acetilneuraminico y su ulitizacion como agentes antiviricos.
ES91908682T Expired - Lifetime ES2113881T3 (es) 1990-04-24 1991-04-24 Derivados y analogos de acido 2-desoxi-2,3-didehidro-n-acetil neuraminico y su utilizacion como agentes antivirales.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES97100119T Expired - Lifetime ES2313730T3 (es) 1990-04-24 1991-04-24 Derivados y analogos del acido 2-desoxi-2,3-deshibro-n-acetilneuraminico y su ulitizacion como agentes antiviricos.

Country Status (37)

Country Link
US (2) US5360817A (es)
EP (2) EP0786458B1 (es)
JP (1) JP2944750B2 (es)
KR (1) KR0169496B1 (es)
CN (3) CN1036849C (es)
AP (1) AP249A (es)
AT (2) ATE161253T1 (es)
AU (2) AU654815B2 (es)
BG (1) BG62092B1 (es)
CA (2) CA2081356C (es)
CY (1) CY2186B1 (es)
CZ (1) CZ288492B6 (es)
DE (3) DE69128469T2 (es)
DK (1) DK0526543T3 (es)
ES (2) ES2313730T3 (es)
FI (2) FI105478B (es)
GR (1) GR3026225T3 (es)
HK (2) HK1003834A1 (es)
HU (2) HU219355B (es)
IE (2) IE911372A1 (es)
IL (1) IL97936A (es)
LU (1) LU90468I2 (es)
MY (1) MY107843A (es)
NL (1) NL990030I2 (es)
NO (3) NO302751B1 (es)
NZ (1) NZ237936A (es)
OA (1) OA09679A (es)
PL (3) PL166918B1 (es)
PT (1) PT97460B (es)
RU (1) RU2119487C1 (es)
SG (1) SG43170A1 (es)
SI (1) SI9110745B (es)
SK (1) SK282950B6 (es)
UA (1) UA41252C2 (es)
WO (1) WO1991016320A1 (es)
YU (1) YU48741B (es)
ZA (1) ZA913086B (es)

Families Citing this family (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2081068C (en) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
GB9126725D0 (en) * 1991-12-17 1992-02-12 Glaxo Group Ltd Process
GB9220241D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9220327D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9312531D0 (en) * 1993-06-17 1993-08-04 Glaxo Group Ltd Process
US5958973A (en) * 1993-09-03 1999-09-28 Gilead Sciences, Inc. Polyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitors
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9400206D0 (en) * 1994-01-07 1994-03-02 Glaxo Group Ltd Chemical compound
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
US5453533A (en) * 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
EP0711766B1 (en) * 1994-05-27 2000-02-16 Daikin Industries, Limited 7-fluoro-2, 3-didehydrosialic acid and intermediate for synthesis thereof
GB9410817D0 (en) * 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
AUPM725794A0 (en) * 1994-08-03 1994-08-25 Biota Scientific Management Pty Ltd Chemical compounds
US5556963A (en) * 1994-08-05 1996-09-17 Oklahoma Medical Research Foundation Synthesis of 4-alkoxy-N-acetylneuraminic acid
GB9416365D0 (en) * 1994-08-12 1994-10-05 Glaxo Group Ltd Medicaments
US5512596A (en) * 1994-09-02 1996-04-30 Gilead Sciences, Inc. Aromatic compounds
US5475109A (en) * 1994-10-17 1995-12-12 Merck & Co., Inc. Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
AU4259500A (en) * 1995-02-27 2000-08-31 Gilead Sciences, Inc. Novel compounds and methods for synthesis and therapy
CN101143859A (zh) * 1995-02-27 2008-03-19 吉里德科学公司 新颖化合物,其合成方法及治疗用途
JP3300365B2 (ja) * 1995-02-27 2002-07-08 ギリアード サイエンシーズ，インコーポレイテッド ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
DK0976734T3 (da) * 1995-02-27 2005-12-27 Gilead Sciences Inc Selektive inhibitorer af viral eller bakteriel neuraminidase
US5602277A (en) * 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
AU709127B2 (en) * 1995-05-19 1999-08-19 Biota Scientific Management Pty Ltd 6-carboxamido dihydropyran derivatives
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
JPH0967270A (ja) * 1995-08-31 1997-03-11 Res Dev Corp Of Japan 水晶体混濁の予防および治療法、並びにそのための薬 剤
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
HU223099B1 (hu) 1996-03-01 2004-03-29 Biota Scientific Managemant Pty. Ltd. Eljárás influenzavírus kimutatására és az eljárásban alkalmazható vegyületek
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
ATE211468T1 (de) * 1996-07-22 2002-01-15 Sankyo Co Neuraminsäuredervate, ihre herstellung und medizinische verwendung
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
DE69721553T2 (de) * 1996-08-13 2004-07-22 Sankyo Co., Ltd. Verbindungen der neuraminsaeure
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
EP0882721A4 (en) * 1996-09-10 1999-12-22 Daikin Ind Ltd 4-SUBSTITUTED 2,7-DIDEOXY-7-FLUORO-2,3-DIDEHYDRO SIAL ACIDS
US5719020A (en) * 1996-09-25 1998-02-17 Oklahoma Medical Research Foundation 4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses in clinical specimens
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
WO1998017647A1 (en) * 1996-10-21 1998-04-30 Gilead Sciences, Inc. Piperidine compounds
HUP9904009A3 (en) * 1996-11-14 2001-07-30 Biota Scient Man Pty Ltd Melbo Method and novel compounds for use therein
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
JP3390965B2 (ja) 1997-09-12 2003-03-31 理化学研究所 糖結合スフィンゴシンを含有するポリマー化合物
NZ502988A (en) * 1997-09-17 2002-08-28 Gilead Sciences Inc 5-Acetamido-4-amino-2-propionyloxy-6-isopropoxy-1-cyclohexene useful for treating influenza
US20040053999A1 (en) * 1997-09-17 2004-03-18 Bischofberger Norbert W. Novel compounds and methods for synthesis and therapy
US20030129146A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti The use of bacterial phage associated lysing proteins for treating bacterial dental caries
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
CA2329660A1 (en) * 1998-04-23 1999-10-28 Abbott Laboratories Inhibitors of neuraminidases
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
AP2001002051A0 (en) 1998-07-15 2001-03-31 Hassan Jomaa Phosphorous organic compounds and their use.
US6303764B1 (en) 1998-09-24 2001-10-16 Zymetx, Inc. Synthesis of 4,7-dialkyl chromogenic glycosides of N-acetylneuraminic acids
US6664235B1 (en) 1999-08-20 2003-12-16 Riken Medicaments comprising sialic acid derivatives as active ingredients
US6420552B1 (en) 1999-09-10 2002-07-16 Zymetx, Inc. Syntheses of 4-alkyl chromogenic glycosides and 7-alkyl chromogenic glycosides of N-acetylneuraminic acids
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
WO2001029020A2 (en) * 1999-10-19 2001-04-26 Abbott Laboratories Neuraminidase inhibitors
US6627396B1 (en) 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
CA2895884C (en) 2000-03-06 2019-04-23 University Of Kentucky Research Foundation A compound that selectively binds to cd123 and use thereof to kill hematologic cancer progenitor cells
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
CA2459040A1 (en) * 2001-09-14 2003-03-27 Mimeon, Inc. Methods of making glycolmolecules with enhanced activities and uses thereof
JP2006241024A (ja) * 2005-03-01 2006-09-14 Takashi Suzuki 新規シアル酸誘導体
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
CN100471848C (zh) * 2006-06-05 2009-03-25 中国医学科学院医药生物技术研究所 一组长链烷氧烷基取代唾液酸衍生物及其制备方法
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
US8227425B2 (en) 2007-01-23 2012-07-24 Therapicon Srl Antiviral compounds
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
US7981930B2 (en) * 2007-03-13 2011-07-19 Adamas Pharmaceuticals, Inc. Compositions and kits for treating influenza
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
JP2010524467A (ja) 2007-04-16 2010-07-22 モメンタ ファーマシューティカルズ インコーポレイテッド 規定の糖タンパク質産物および関連の方法
KR101535691B1 (ko) * 2007-08-31 2015-07-09 아카데미아 시니카 항­인플루엔자 활성을 갖는 포스포네이트 동종체를 함유하는 오셀타미비르의 합성
EP2276479B1 (en) 2008-04-15 2014-07-02 SineVir Therapeutics LLC Prodrugs of neuraminidase inhibitors
WO2010009271A2 (en) 2008-07-15 2010-01-21 Academia Sinica Glycan arrays on ptfe-like aluminum coated glass slides and related methods
WO2010061182A2 (en) 2008-11-28 2010-06-03 Cipla Limited Process for preparing zanamivir and intermediates for use in the process
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
EP2228054A1 (en) 2009-03-13 2010-09-15 ITALFARMACO S.p.A. Riluzole aqueous suspensions
WO2010127443A1 (en) * 2009-05-04 2010-11-11 National Research Council Of Canada Inhibitors of sialidase or sialidase-like enzymes
MX2011012134A (es) 2009-05-15 2012-02-08 Redx Pharma Ltd Derivados de farmaco de oxido-reduccion.
CN102471361B (zh) * 2009-07-15 2016-06-01 不列颠哥伦比亚大学 作为神经氨酸酶抑制剂的2,3-氟化糖苷及其作为抗病毒药物的用途
AU2010273184B2 (en) * 2009-07-16 2015-07-09 Griffith University Anti -influenza agents
IT1396620B1 (it) 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
JP2011136964A (ja) * 2009-12-28 2011-07-14 Gifu Univ ノイラミン酸誘導体、シアリダーゼ活性阻害剤及び抗インフルエンザ薬
ES2602108T3 (es) 2010-04-07 2017-02-17 Momenta Pharmaceuticals, Inc. Método para cuantificar glicoformas que contienen alta manosa
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
WO2011143262A2 (en) 2010-05-10 2011-11-17 Sinica, Academia Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
CN101921251B (zh) * 2010-09-21 2011-10-05 仙居县圃瑞药业有限公司 扎那米韦中间体的精制工艺方法
CN102464640A (zh) * 2010-10-29 2012-05-23 江苏正大天晴药业股份有限公司 扎那米韦的制备方法
AT510585B1 (de) 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
WO2012114350A1 (en) 2011-02-24 2012-08-30 Cadila Healthcare Limited Process for the preparation of zanamivir
WO2012125553A2 (en) 2011-03-12 2012-09-20 Momenta Pharmaceuticals, Inc. N-acetylhexosamine-containing n-glycans in glycoprotein products
WO2012142492A2 (en) * 2011-04-15 2012-10-18 University Of Georgia Research Foundation, Inc. Methods for inhibiting virus replication
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
GB2498080A (en) 2011-12-21 2013-07-03 Redx Pharma Ltd Derivatives of oseltamivir
KR102128413B1 (ko) * 2012-01-19 2020-07-01 더 유니버시티 오브 브리티쉬 콜롬비아 3' 적도방향 불소 치환된 뉴라미니다제 저해제 화합물 및 항바이러스제로 사용하기 위한 이의 조성물 및 방법
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2013181575A2 (en) 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods related to denosumab
WO2014031498A1 (en) 2012-08-18 2014-02-27 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
US9227990B2 (en) 2012-10-29 2016-01-05 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
US10450361B2 (en) 2013-03-15 2019-10-22 Momenta Pharmaceuticals, Inc. Methods related to CTLA4-Fc fusion proteins
EP2996772B1 (en) 2013-05-13 2018-12-19 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
EP3013365B1 (en) 2013-06-26 2019-06-05 Academia Sinica Rm2 antigens and use thereof
EP3013347B1 (en) 2013-06-27 2019-12-11 Academia Sinica Glycan conjugates and use thereof
CN103396957B (zh) * 2013-07-11 2015-08-19 中国海洋大学 一种来源于鲤链霉菌的海洋微生物多糖及其制备方法
CN105682666B (zh) 2013-09-06 2021-06-01 中央研究院 使用醣脂激活人类iNKT细胞
CN111018901B (zh) * 2013-09-09 2021-09-03 中国科学院上海有机化学研究所 扎那米韦和拉那米韦的中间体及其合成方法
EP3058084A4 (en) 2013-10-16 2017-07-05 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
JP6453050B2 (ja) * 2013-11-15 2019-01-16 国立大学法人富山大学 ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法
WO2015109180A2 (en) 2014-01-16 2015-07-23 Academia Sinica Compositions and methods for treatment and detection of cancers
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
TWI797430B (zh) 2014-03-27 2023-04-01 中央研究院 反應性標記化合物及其用途
CN107072976A (zh) 2014-05-12 2017-08-18 葛兰素史克知识产权第二有限公司 用于治疗传染性疾病的包含Danirixin的药物组合物
KR102576850B1 (ko) 2014-05-27 2023-09-11 아카데미아 시니카 박테로이드 기원의 푸코시다제 및 이의 사용 방법
JP7062361B2 (ja) 2014-05-27 2022-05-06 アカデミア シニカ 抗ｈｅｒ２糖操作抗体群およびその使用
CA2950415A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-cd20 glycoantibodies and uses thereof
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
KR102494193B1 (ko) 2014-05-28 2023-01-31 아카데미아 시니카 항-ｔｎｆ-알파 글리코항체 및 이의 용도
NL2013420B1 (en) * 2014-09-05 2016-09-27 Univ Griffith Antiviral agents and uses thereof.
JP6899321B2 (ja) 2014-09-08 2021-07-07 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 糖脂質を使用するヒトｉＮＫＴ細胞活性化
US10328143B2 (en) 2014-10-24 2019-06-25 Peptidream Inc. Hemagglutinin-binding peptide
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
TWI736523B (zh) 2015-01-24 2021-08-21 中央研究院 新穎聚醣結合物及其使用方法
JP2019515876A (ja) 2016-03-08 2019-06-13 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ Ｎ−グリカンおよびそのアレイのモジュール合成のための方法
EP3500594A4 (en) 2016-08-22 2020-03-11 Cho Pharma Inc. ANTIBODIES, BINDING FRAGMENTS AND METHOD FOR USE
CN106520864A (zh) * 2016-09-28 2017-03-22 南京农业大学 一种酶法合成唾液酸类似物的方法及其应用
CA3064774A1 (en) * 2017-05-25 2018-11-29 The Governors Of The University Of Alberta Methods of preventing or treating atherosclerosis with inhibitors of specific isoenzymes of human neuraminidase
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
CN118488831A (zh) 2021-12-23 2024-08-13 苏宾特罗有限公司 包含油酸的新抗病毒组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL287642A (es) 1962-01-18

Also Published As

Publication number Publication date
ES2313730T3 (es) 2009-03-01
MY107843A (en) 1996-06-29
HK1003834A1 (en) 1998-11-06
SI9110745A (en) 1997-04-30
ATE406358T1 (de) 2008-09-15
CN1036849C (zh) 1997-12-31
AP249A (en) 1993-03-17
RU2119487C1 (ru) 1998-09-27
YU48741B (sh) 1999-09-27
IL97936A (en) 1995-12-08
NZ237936A (en) 1997-08-22
IE980526A1 (en) 2003-10-15
FI924790A0 (fi) 1992-10-22
CZ288492B6 (en) 2001-06-13
CA2291994A1 (en) 1991-10-25
SG43170A1 (en) 1997-10-17
HU210717A9 (en) 1995-06-28
HUT61989A (en) 1993-03-29
EP0786458A2 (en) 1997-07-30
PL166918B1 (pl) 1995-07-31
NL990030I2 (nl) 2000-02-01
WO1991016320A1 (en) 1991-10-31
PT97460B (pt) 1999-01-29
DE19975068I1 (de) 2000-01-13
CA2081356C (en) 2000-02-22
NL990030I1 (nl) 1999-12-01
US5648379A (en) 1997-07-15
KR0169496B1 (ko) 1999-01-15
EP0786458B1 (en) 2008-08-27
DK0526543T3 (da) 1998-08-24
EP0526543A4 (en) 1993-04-21
JP2944750B2 (ja) 1999-09-06
PL167192B1 (pl) 1995-08-31
IE911372A1 (en) 1991-11-06
US5360817A (en) 1994-11-01
ATE161253T1 (de) 1998-01-15
CN1057260A (zh) 1991-12-25
PL167630B1 (pl) 1995-10-31
DE69128469T2 (de) 1998-06-04
HU9203180D0 (en) 1992-12-28
CS114591A3 (en) 1991-12-17
AP9100253A0 (en) 1991-04-30
CA2081356A1 (en) 1991-10-25
UA41252C2 (uk) 2001-09-17
GR3026225T3 (en) 1998-05-29
BG96978A (bg) 1993-12-24
OA09679A (en) 1993-05-15
CY2186B1 (en) 2002-11-08
YU74591A (sh) 1994-06-24
EP0526543A1 (en) 1993-02-10
EP0786458A3 (en) 1999-10-13
DE69128469D1 (de) 1998-01-29
FI924790A (fi) 1992-10-22
CN1143853C (zh) 2004-03-31
ZA913086B (en) 1992-12-30
CA2291994C (en) 2003-10-14
HU219355B (en) 2001-03-28
PT97460A (pt) 1992-01-31
FI20001231A (fi) 2000-05-23
AU7759091A (en) 1991-11-11
NO302751B1 (no) 1998-04-20
CN1091594C (zh) 2002-10-02
SK282950B6 (sk) 2003-01-09
CN1150020A (zh) 1997-05-21
AU7533891A (en) 1991-12-12
NO974670D0 (no) 1997-10-09
NO923944L (no) 1992-12-18
NO923944D0 (no) 1992-10-09
FI105478B (fi) 2000-08-31
DE19975068I2 (de) 2002-10-10
NO1999021I1 (no) 1999-09-17
AU654815B2 (en) 1994-11-24
JPH05507068A (ja) 1993-10-14
EP0526543B1 (en) 1997-12-17
NO974670L (no) 1992-12-18
CN1184108A (zh) 1998-06-10
BG62092B1 (bg) 1999-02-26
SI9110745B (en) 2001-06-30
DE69133604D1 (de) 2008-10-09
HK1010191A1 (en) 1999-06-17
LU90468I2 (fr) 2000-01-03

Similar Documents

Publication Publication Date Title
ES2113881T3 (es) Derivados y analogos de acido 2-desoxi-2,3-didehidro-n-acetil neuraminico y su utilizacion como agentes antivirales.
ES2075011T3 (es) Uso de sales del acido gamma-hidroxibutirico para preparar composiciones farmaceuticas para uso en el tratamiento del alcoholismo, y las composiciones obtenidas.
DK224286A (da) 2',3'-dideoxy-nucleosider
ES2093694T3 (es) Nuevos derivados de dihidro-isoquinoleina.
ES2087639T3 (es) Nucleosidos terapeuticos.
ES2118835T3 (es) 2-etil-1h-imidazo(4,5-c)quinolin-4-aminas antiviricas.
MX9204474A (es) Analogos nucleosidos 1,3-oxatiolano.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2170141T3 (es) 4-aminoderivados del acido micofenolico con actividad inmunosupresora.
ES2138969T3 (es) Combinacion de nucleosidos antivirales.
ES2147294T3 (es) Compuestos terapeuticos.
FI904445A0 (fi) Antivirala foereningar.
ES2061453T3 (es) Composiciones farmaceuticas antivirales que contienen hipericina o pseudohipericina.
ES2108969T3 (es) Utilizacion de analogos de didesoxinucleosidos en el tratamiento de infecciones virales.
AR007997A1 (es) Un derivado de distamicina sustituida con acriloilo, sus utilizaciones, un procedimiento para producirlo y una composicion farmaceutica que lo comprende.
ATE36331T1 (de) Guanin-derivate, diese enthaltende zusammensetzungen und ihre antivirale wirkung.
ATE71840T1 (de) Virushemmende nukleosidmischung.
MC1930A1 (fr) Produit antiviral
ES2036532T3 (es) Nucleosidos de isohexida, procedimientos para su preparacion y su uso como medicamentos.
MX9303985A (es) Nucleosidos terapeuticos.
ES2055440T3 (es) Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.
ES2150034T3 (es) Empleo de las 2-aminotetralinas substituidas en 6,7 para la preparacion de composiciones farmaceuticas de utilidad para el tratamiento del choque septico, y composiciones farmaceuticas antipireticas y antiinflamatorias.
DE68914809D1 (de) Antivirale Wirkstoffe.
SE7904840L (sv) Antiviralt verksamma t-rna-preparat
IT1212737B (it) Derivati pirimidinici ad azione antivirale.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 526543

Country of ref document: ES

SPCF Request for supplementary protection certificate filed

Free format text: ZANAMIVIR (RELENZA)

Spc suppl protection certif: C9900040

Filing date: 19991028

SPCG Supplementary protection certificate granted

Free format text: ZANAMIVIR (RELENZA)

Spc suppl protection certif: C9900040

Filing date: 19991028

Expiry date: 20140209

Effective date: 20030310